India to Myanmar: Ampicillin Export Trade Route
India has recorded 144 verified shipments of Ampicillin exported to Myanmar, representing a combined trade value of $7.8M USD. This corridor is served by 22 active Indian exporters, with an average shipment value of $54.3K USD. The leading Indian exporter is AMN LIFE SCIENCE PRIVATE LIMITED, which accounts for 51% of total export value with 45 shipments worth $4.0M USD. On the buying side, AORTA COMPANY LIMITED is the largest importer in Myanmar with $3.9M USD in purchases. The top 3 suppliers — AMN LIFE SCIENCE PRIVATE LIMITED, AMN LIFE SCIENCE PRIVATE LIMITED , UNICHEM LABORATORIES LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Ampicillin corridor is one of India's established pharmaceutical export routes, with 144 shipments documented worth a combined $7.8M USD. The route is dominated by AMN LIFE SCIENCE PRIVATE LIMITED, which alone accounts for roughly 51% of all export value, reflecting the consolidated nature of India's ampicillin manufacturing sector.
Across 22 active suppliers, the average shipment value stands at $54.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with ampicillin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 26.7%, placing it at rank #16 among India's top ampicillin export destinations globally.
On the import side, key buyers of Indian ampicillin in Myanmar include AORTA COMPANY LIMITED, AORTA COMPANY LIMITED , TO THE ORDER and 31 others. AORTA COMPANY LIMITED is the single largest importer with 44 shipments valued at $3.9M USD.
